Towards Healthcare Research & Consulting

U.S. Radiofrequency Ablation Devices for Pain Management Manufacturers and Recent Developments

Date : 09 June 2026

Latest Updates of Companies in the Market

U.S. Radiofrequency Ablation Devices for Pain Management Market Companies are Medtronic, Boston Scientific, Abbott Laboratories, Avanos Medical, Stryker Corporation

Tier 1
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Boston Scientific Marlborough, Massachusetts USA Major pain management franchise and recent GX1 RF Generator launch GX1 RF Generator System, RF lesioning platforms
Abbott Abbott Park, Illinois USA Strong chronic pain portfolio and dedicated RFA offerings IonicRF Generator, Simplicity RF Denervation System
Medtronic Galway Ireland Global pain management leader with extensive interventional portfolio RF generators, pain intervention systems
Avanos Medical Alpharetta, Georgia USA Market leader in cooled RFA technology COOLIEF Cooled RFA, TRIDENT RF, AVANOS CRG Generator
Stryker Portage, Michigan USA Strong interventional pain and neurotechnology presence Radiofrequency lesioning systems and pain intervention products
Tier 2
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
NeuroTherm Wilmington, Massachusetts USA Long-standing specialist in RF pain management NT Series RF Generators and RF Electrodes
Cosman Medical Burlington, Massachusetts USA Established RF lesioning specialist Cosman G4 RF Generator, RF Cannulas
Diros Technology Toronto, Ontario Canada Specialized RF technology provider; acquired by Avanos but continues as product platform RF Lesion Generators, Trident Technology
Epimed International Farmers Branch, Texas USA Strong disposable pain procedure portfolio RF Needles, Cannulas, Procedure Kits
Merit Medical Systems South Jordan, Utah USA Growing pain intervention presence through specialty procedure products Pain management access devices and procedural tools
Tier 3
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Elevaris Medical Devices Clearwater, Florida USA Emerging participant focused on pain intervention technologies RF procedural accessories
Baylis Medical Technologies Mississauga, Ontario Canada RF expertise and procedural technologies supporting intervention markets RF generators and procedural systems
Halyard Health Alpharetta, Georgia USA Historical COOLIEF platform foundation and pain management legacy Chronic pain RF solutions
SPR Therapeutics Cleveland, Ohio USA Alternative interventional pain innovator competing in chronic pain treatment pathways Peripheral nerve stimulation systems
Nalu Medical Carlsbad, California USA Emerging chronic pain technology competitor influencing pain intervention market Miniaturized neuromodulation systems

Recent Developments in the U.S. Radiofrequency Ablation Devices for Pain Management Market

  • In February 2026, Stratus Medical secured $10 million in Series B funding led by Wasatch Health Partners to advance radiofrequency ablation technology for chronic pain treatment. This investment follows a previous $25 million convertible debt facility provided by Wasatch Health Partners.
  • In August 2025, the Food and Drug Administration (FDA) granted 510(k) clearance to the OneRF Trigeminal Nerve Ablation System (NeuroOne Medical Technologies Corporation [NeuroOne], Eden Prairie, MN), authorizing its use for the treatment of pain or for lesioning nerve tissue during neurosurgical procedures through the creation of radiofrequency lesions. According to a statement released by NeuroOne, the company plans to initiate a limited commercial launch of the device in late 2025.

Market Ecosystem Analysis

Ecosystem Category Key Participants Role in Market
Technology Providers Boston Scientific, Abbott, Avanos, Medtronic, Stryker Develop RFA generators, lesioning technologies, probes, and procedural platforms
Product Manufacturers Avanos, Abbott, Boston Scientific, NeuroTherm, Cosman Medical, Diros Manufacture RFA generators, electrodes, probes, cannulas, disposables
Service Providers Pain clinics, hospital systems, ambulatory surgery centers Deliver RFA procedures to patients
Platform Providers Abbott, Boston Scientific, Medtronic Integrated pain management ecosystems combining RFA and neuromodulation
CROs/CDMOs NAMSA, WuXi AppTec Medical Device Division, Eurofins Medical Device Testing Clinical validation and regulatory support
Software Vendors Brainlab, Medtronic Navigation, Stryker Navigation Imaging, targeting, and procedural planning support
Research Institutions Mayo Clinic, Cleveland Clinic, Stanford Pain Center, Johns Hopkins Clinical evidence generation and physician training
End-User Industries Hospitals, ASCs, Specialty Pain Centers, Orthopedic Centers Primary purchasing and utilization environments

Market Growth

The U.S. radiofrequency ablation devices for pain management market size was estimated at USD 385 million in 2025 and is predicted to increase from USD 430.43 billion in 2026 to approximately USD 1174.57 million by 2035, expanding at a CAGR of 11.8% from 2026 to 2035.U.S. Radiofrequency Ablation Devices for Pain Management Market Size is USD 430.43 Million in 2026.